Spinogenix Inc
San Diego, USA
|
Description:
Spinogenix, Inc., a preclinical stage, privately-held pharmaceutical company is developing drugs to reverse synapse loss and restore connections lost to neurodegenerative diseases. The company's neurorestorative compounds are designed to restore synapses in order to enhance brain connections and improve memory. Spinogenix’s lead drug candidate has a unique mechanism of action wherein it induces an increase in synapses.
Spinogenix, Inc., a preclinical stage, privately-held pharmaceutical company is developing drugs to reverse synapse loss and restore connections lost to neurodegenerative diseases. The company's neurorestorative compounds are designed to restore synapses in order to enhance brain connections and improve memory. Spinogenix’s lead drug candidate has a unique mechanism of action wherein it induces an increase in synapses.